Optimal summary of information in longitudinal CA125 measurements for efficient ovarian cancer screening

被引:0
|
作者
Skates, SJ [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA
来源
JOURNAL OF CLINICAL LIGAND ASSAY | 2000年 / 23卷 / 02期
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Ovarian cancer mortality rates have changed little over 30 years despite therapeutic advances. Given the large proportion of cases discovered in late stages and consequent poor prognosis, and the excellent prognosis if discovered in early stages, screening is an appealing approach to investigate reducing ovarian cancer mortality, Due to the large scale of screening programs end the low incidence of ovarian cancer, it is paramount that the screening strategy is as efficient as possible. CA125 is a marker for ovarian cancer that shows promise in detecting most ovarian cancers preclinically. However, its efficiency could be substantially improved if longitudinal CA125 values were taken into account in the screening program, We provide a detailed description, with minimal mathematical notation, of a systematic statistical calculation to optimally summarize the information in longitudinal CA125 values. Based on this calculation we describe a strategy, called the risk of ovarian cancer algorithm (ROCA), which implements an efficient approach to screening for ovarian cancer based on longitudinal CA125 measurements.
引用
收藏
页码:150 / 154
页数:5
相关论文
共 50 条
  • [1] Personalizing CA125 Levels for Ovarian Cancer Screening
    Dorigo, Oliver
    Berek, Jonathan S.
    CANCER PREVENTION RESEARCH, 2011, 4 (09) : 1356 - 1359
  • [2] CA125 in ovarian cancer
    Scholler, Nathalie
    Urban, Nicole
    BIOMARKERS IN MEDICINE, 2007, 1 (04) : 513 - 523
  • [3] Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
    Gupta, Digant
    Lammersfeld, Carolyn A.
    Vashi, Pankaj G.
    Braun, Donald P.
    JOURNAL OF OVARIAN RESEARCH, 2010, 3
  • [4] Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
    Digant Gupta
    Carolyn A Lammersfeld
    Pankaj G Vashi
    Donald P Braun
    Journal of Ovarian Research, 3
  • [5] LONGITUDINAL-STUDY OF CEA AND CA125 IN OVARIAN-CANCER
    BRIOSCHI, PA
    BISCHOF, P
    RAPIN, C
    DEROTEN, M
    IRION, O
    KRAUER, F
    GYNECOLOGIC ONCOLOGY, 1985, 21 (01) : 1 - 6
  • [6] CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations
    Cramer, Daniel W.
    O'Rourke, Dennis J.
    Vitonis, Allison F.
    Matulonis, Ursula A.
    DiJohn-son, Daniel A.
    Sluss, Patrick M.
    Crum, Christopher P.
    Liu, Brian C. -S.
    CLINICAL CHEMISTRY, 2010, 56 (12) : 1889 - 1892
  • [7] Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer
    Simmons, Archana R.
    Fourkala, Evangelia Ourania
    Gentry-Maharaj, Aleksandra
    Ryan, Andy
    Sutton, Margie N.
    Baggerly, Keith
    Zheng, Hui
    Lu, Karen H.
    Jacobs, Ian
    Skates, Steven
    Menon, Usha
    Bast, Robert C., Jr.
    CANCER PREVENTION RESEARCH, 2019, 12 (06) : 391 - 399
  • [8] A joint model based on longitudinal CA125 in ovarian cancer to predict recurrence
    Chang, Chung
    Chiang, An Jen
    Chen, Wei-An
    Chang, Hsueh-Wen
    Chen, Jiabin
    BIOMARKERS IN MEDICINE, 2016, 10 (01) : 53 - 61
  • [9] Ovarian cancer: the duplicity of CA125 measurement
    Amer K. Karam
    Beth Y. Karlan
    Nature Reviews Clinical Oncology, 2010, 7 : 335 - 339
  • [10] Ovarian cancer: the duplicity of CA125 measurement
    Karam, Amer K.
    Karlan, Beth Y.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 335 - 339